chr16-28872520-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001387430.1(SH2B1):c.1726-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,603,166 control chromosomes in the GnomAD database, including 112,290 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 7956 hom., cov: 32)
Exomes 𝑓: 0.37 ( 104334 hom. )
Consequence
SH2B1
NM_001387430.1 intron
NM_001387430.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0250
Genes affected
SH2B1 (HGNC:30417): (SH2B adaptor protein 1) This gene encodes a member of the SH2-domain containing mediators family. The encoded protein mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular transformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-28872520-C-T is Benign according to our data. Variant chr16-28872520-C-T is described in ClinVar as [Benign]. Clinvar id is 1594692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2B1 | NM_001387430.1 | c.1726-14C>T | intron_variant | Intron 6 of 7 | ENST00000684370.1 | NP_001374359.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.284 AC: 43190AN: 152010Hom.: 7944 Cov.: 32
GnomAD3 genomes
AF:
AC:
43190
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.334 AC: 82118AN: 245952Hom.: 16012 AF XY: 0.330 AC XY: 43748AN XY: 132678
GnomAD3 exomes
AF:
AC:
82118
AN:
245952
Hom.:
AF XY:
AC XY:
43748
AN XY:
132678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.369 AC: 534765AN: 1451038Hom.: 104334 Cov.: 36 AF XY: 0.364 AC XY: 262403AN XY: 719952
GnomAD4 exome
AF:
AC:
534765
AN:
1451038
Hom.:
Cov.:
36
AF XY:
AC XY:
262403
AN XY:
719952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.284 AC: 43210AN: 152128Hom.: 7956 Cov.: 32 AF XY: 0.283 AC XY: 21078AN XY: 74362
GnomAD4 genome
AF:
AC:
43210
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
21078
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
735
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at